To include your compound in the COVID-19 Resource Center, submit it here.
Ascendis Pharma A/S (NASDAQ:ASND) and Catalent Inc. (NYSE:CTLT) each priced follow-on offerings, raising more than $380 million.
Ascendis raised $134.9 million on Wednesday through the sale of 3.8 million ADSs
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury